Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Lumexa Imaging Holdings Q3 2026 Results: Turns Profitable, Net Income $7.18M

Lumexa Imaging Holdings reported a net income of $7.2 million for the third quarter of 2026, a significant recovery from a $3.5 million loss in the prior year period. Total revenues grew to $272.0 million, driven by increases in net patient service and management fee revenue, while the company maintained a strong cash position of $90.0 million.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue272.0258.9
Profit before tax11.8-0.2
Net income7.2-3.5
EPS (diluted, $ a share)$0.07$-0.05

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+5.0%
Operating margin10.3%
Source

10-Q filed with the SEC, NASDAQ: LMRI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Lumexa Imaging Holdings, Inc.: key numbers

Share price
$14.79Close, Nov 16
Market cap
$1.42B
Shares outstanding
96.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Medical LaboratoriesSIC 8071

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Lumexa Imaging Holdings, Inc.

All →
4:07 PM ET 8-K
Financial Results

Lumexa Imaging Holdings Financial Results

Lumexa Imaging reported Q3 2026 financial results with revenue growing 5% to $272.0 million and net income of $7.2 million. The company reiterated its full-year revenue guidance while raising its Adjusted EPS outlook to $0.86–$0.90 due to a lower effective tax rate.

Term
Q3 2026

“In Q3, we advanced our business in several meaningful ways while executing against our strategy. Advanced modalities reached a record high as a percent of our volumes, and our newer de novo cohorts continue to ramp on plan. We are actively opening three new de novo centers and are on pace to achieve our goal for 8–10 new center openings this year.”

Caitlin Zulla, Chief Executive Officer of Lumexa Imaging

“We are leading a transformation in healthcare - delivering high-quality imaging in more convenient settings, more quickly and at meaningfully lower cost through our wholly owned centers and alongside health system partners, improving clinical and financial outcomes.”

Caitlin Zulla, Chief Executive Officer of Lumexa Imaging

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.